NERV Income Statement


* In Millions (except for per share items) of USD
Period Ending: LTM
(Last Twelve Months)
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
2015
12-31
2014
12-31
2013
12-31
2012
12-31
Report Filing: 2024-02-22 2023-03-08 2022-03-01 2021-03-08 2020-03-09 2019-03-12 2018-03-12 2017-03-13 2016-03-14 2015-03-26 2013-12-31 2012-12-31
Revenue 0 0 0 41175600 0 0 0 0 0 0 0 0
Cost of Revenue 30982 8513 101786 0 161507 0 0 0 0 0 0 0
Gross Profit -30982 -8513 -101786 41175600 -161507 0 0 0 0 0 0 0
Operating Expenses 23088598 25222813 45263871 39328853 75703589 51729882 41170161 30190696 26109619 54870431 3174979 1581016
Research & Development 12705253 14649087 32038947 22039440 58123000 34888574 30255892 20439994 18533363 42908566 708489 550360
Selling, General and Administrative 10383341 10582239 13326710 17289413 17741000 16841308 10914269 9750702 7576256 11961865 2466490 1030656
Other Operating Expenses 4 -8513 -101786 0 -160411 0 0 0 0 0 0 0
Operating Income -23119580 -25231326 -45365657 1846747 -75865096 -51729882 -41170161 -30190696 -26109619 -54870431 -3174979 -1581016
Net Interest(Non Operating) -6845542 -6849609 -6310805 161207 1456019 1563442 327569 -831734 -956160 -2049735 -58049 7
Interest Income 1437405 556946 16516 161207 1456019 1673890 941833 198000 96910 0 1559 7
Interest Expense 8282947 7406555 6327321 0 0 110448 614264 1029734 1053070 2049735 59608 0
Equity & Other Income/(Expense) -40231 -27741 -32846 -67183 -27923 -4847 -56887 -22942 -15853 18727 -28977 -946
Income Before Tax -30005353 -32108676 -51709308 1940771 -74437000 -50171287 -40899479 -31045372 -27081632 -56901439 -3262005 -1581955
Income Tax Expense -2 6877350 -1803356 -94024 -2254000 1669043 -9376272 1029734 1053070 2049735 58049 -7
Income Attributable to Non-Controlling Interest 2 0 0 94024 0 -1669043 0 -1029734 -1053070 -2049735 -58049 7
Net Income -30005353 -38986026 -49905952 1940771 -72183000 -50171287 -31523207 -31045372 -27081632 -56901439 -3262005 -1581955
Depreciation and Amortization 30982 8513 101786 82153 1096 17467 11094 16530 17276 33869 1559 7
EBITDA -23088598 -25222813 -45263871 1928900 -75864000 -51712415 -41159067 -30174166 -26092343 -54836562 -3173420 -1581009
Earnings Per Share (EPS) -4.61 -7.3 -9.35 0.38 -14.8 -10.35 -6.65 -7.88 -9.25 -35.77 -1.43 -0.69
Diluted Earnings Per Share -4.61 -7.3 -9.35 0.38 -14.8 -10.35 -6.65 -7.88 -9.25 -35.77 -1.43 -0.69
Weighted Average Shares Outstanding 6506372 5340194 5340195 5102964 4876787 4849072 4742148 3939269 2926522 1590549 2284760 2284760
Diluted Weighted Average Shares Outstanding 6506372 5340194 5340195 5114608 4876787 4849072 4742148 3939269 2926522 1590549 2284760 2284760

Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.